Compare · RADPAIR and PowerScribe

RadPair vs PowerScribe vs Rad AI and how the three radiology reporting platforms compare

The short answer

RADPAIR, Nuance PowerScribe and Rad AI all touch the radiology report, but only one of them is the system your report is written in. PowerScribe is the reporting platform of record for much of US radiology, and PowerScribe 360 annual renewals and maintenance ended on August 31, 2026. RADPAIR, founded in 2023 in Knoxville, Tennessee, is a fully web-based generative AI reporting platform that replaces the dictation and drafting layer outright, and it is the only one of the three that publishes a self-serve trial and pay-as-you-go pricing. Rad AI is not a replacement at all: it layers impression generation and follow-up tracking on top of the reporting platform you already run.

These three names land on the same shortlist for a reason that has nothing to do with them being similar products. Groups start looking because the PowerScribe 360 clock is running, and once you start looking, every vendor that touches the report shows up in the same search results. The useful first question is not which is best, it is which of them would actually replace what you have.

RADPAIR replaces the reporting workstation. It is web-based with nothing to install, you dictate into it, and generative models draft findings and impressions you edit and sign. Rad AI does not replace it: Rad AI Impressions writes the impression inside your existing platform and Rad AI Continuity chases incidental-finding follow-ups after the report is signed. PowerScribe is the thing the other two are measured against. The table below sets all three side by side on published vendor material only, including the rows where each one wins.

Radiological.ai is not a column in that table. We are a decision-support assistant that flags suspected findings, prioritizes the worklist and drafts the structured report across X-ray, CT and MRI, and the radiologist reviews, edits and signs every study. This page exists because the comparison between these three is genuinely hard to find written down honestly.

The Reading Station

Assistant ready

Worklist

Not for diagnostic use

Structured report

Draft

Run the assistant to draft this report for review.

You review & sign

Decision support. The radiologist reviews and signs every study.

Drafted in · you review & sign Worklist re-prioritized

Decision support for qualified clinicians. Radiological.ai does not provide a diagnosis and is not a substitute for professional judgment.

See the comparison

Flag · prioritize · draft · you review and sign

PowerScribe is the platform of record with a hard 2026 renewal deadline, RADPAIR is the web-based generative replacement with the only published self-serve pricing of the three, and Rad AI is a layer on top of whichever platform you keep.

Side by side

RadPair vs PowerScribe vs Rad AI, side by side

Compiled only from each company's own published material and press announcements. No column is the sales column, and each vendor leads on different rows.

What you are comparing	RADPAIR	Nuance PowerScribe	Rad AI
What it replaces	The reporting and dictation workstation outright	Nothing, it is the incumbent platform of record	Nothing, it layers on top of the platform you already run
Company and origin	RADPAIR, founded 2023, Knoxville, Tennessee	Nuance Communications, acquired by Microsoft	Rad AI, San Francisco, venture backed
Named products	RADPAIR, with PAIR INSIGHTS and a WINGMAN AI co-pilot	PowerScribe 360 and its successor PowerScribe One	Rad AI Reporting, Rad AI Impressions, Rad AI Continuity
How the report gets drafted	Dictate naturally, generative models format and draft findings and impressions	Speech recognition into your template; PowerScribe One adds Smart Impression	Impressions generates the impression in each radiologist's own language
Deployment	Fully web-based, no installation, the company describes zero footprint	PowerScribe One is cloud-hosted subscription; 360 is the on-premises generation	Cloud service integrated into your existing reporting platform
Notable partnership	Intelerad prime partnership announced May 20, 2025; Intelerad is now a GE HealthCare company	Sits inside the wider Microsoft health portfolio alongside Dragon Copilot	Strategic investment from Advocate Health, Atlantic Health System, Corewell Health Ventures and Memorial Hermann Health System
Follow-up and incidental findings	Not a published product area	PowerScribe One includes EMR follow-up among its named capabilities	Continuity closes the loop on follow-up recommendations and tracks more than 50 categories of incidental findings
Efficiency the vendor claims	Early user feedback of a 30% to 40% reporting efficiency gain versus traditional smart reporting, reported in the Intelerad announcement	No single headline efficiency figure published for the platform	60+ minutes saved per shift, up to 35% fewer words dictated, 84% reporting reduced burnout
Pricing model published	Yes: a 7-day trial with 20 free reports and no credit card, then pay-as-you-go credits, with enterprise licensing on request	No list pricing published; quoted per site and usually contracted through a reseller	No list pricing published; enterprise agreement after a scoping call
US federal contract footprint	No prime awards found naming the product	165 prime awards naming PowerScribe totaling $38,202,976, of which about 65% went through the reseller Carahsoft and 4.1% direct to Nuance	No prime awards found naming the product
Forcing deadline on the buyer	None; you move when you choose to	PowerScribe 360 annual renewals and maintenance ended on August 31, 2026 and full support ends August 31, 2027	None; it adapts to whichever platform you keep
Security posture published	Not detailed on the public site	Enterprise agreements handled through Microsoft contracting	SOC 2 Type II and HIPAA compliance stated on the company site
Regulatory status claimed	No regulatory-status claims on the public site	Documentation product rather than a cleared diagnostic device	No FDA clearance claimed for the reporting products
Best suited for	Groups and teleradiologists who want to leave the installed workstation behind, and individuals who want to try before contracting	Departments that need the incumbent, or that are moving to One to keep templates and stay inside one vendor	Groups keeping their reporting platform who want the impression and follow-up burden reduced

Compiled from radpair.com, the Intelerad and RADPAIR partnership announcement of May 20, 2025, radai.com product and news pages, Microsoft and Nuance PowerScribe product material, and prime award records from USAspending.gov. Vendor claims are labeled as vendor claims. Confirm current capabilities, integrations and contract terms directly with each company before building a shortlist around this table.

Side by side

Radiological.ai vs RADPAIR and PowerScribe, honestly

A fair look at what each does well. Both are capable tools. Here is where they differ.

What matters	Radiological.ai	RADPAIR and PowerScribe
Scope of the workflow covered	Flagging, worklist order and report drafting in one assistant	All three act on the report; none of them reorders what you read first
Worklist prioritization	Suspected-critical studies surface to the top of the list for your review	Not a worklist product in any of the three cases
Finding flags for review	Flags suspected findings as a second set of eyes you confirm	Work on text after you have read the images
Modality coverage	X-ray, CT and MRI across common study types in one pane	Modality agnostic, because the report is the object rather than the image
Regulatory status	Decision support; we make no regulatory-status claims on this site	Documentation products; see the row above for what each publishes
Best suited for	Groups wanting one assistant for flagging, triage and drafting	Groups whose bottleneck is the writing rather than the reading

Comparison reflects general, publicly understood positioning. Capabilities change, so check each product for the latest.

If the PowerScribe side is the part you are actually deciding, the Nuance PowerScribe alternative page covers the switching decision in full, PowerScribe One vs 360 covers the upgrade path Microsoft is pointing you at, and PowerScribe pricing sets out what US federal contracts naming the product actually cost. The PowerScribe 360 end of life timeline has the dates in one place.

If your shortlist is wider than these three, PowerScribe vs Fluency for Imaging compares the other major US reporting vendor, the Rad AI alternative page goes deeper on the impression and follow-up layer, and DeepHealth covers the RadNet-owned entrant. The full grid is on the radiology AI alternatives hub.

Before you sign anything, the vendor evaluation questions are worth sending to all three in the same email so the answers are comparable, who owns your report templates matters more than buyers expect when a migration starts, and the contract terms worth negotiating covers the renewal uplift clause that decides your year-three number.

Why groups pick Radiological.ai

One assistant across the whole read

Work out which layer you are buying

RADPAIR replaces the reporting workstation, Rad AI sits on top of whichever one you keep, and PowerScribe is the one you already have. Buying two products that occupy the same layer is the most common expensive mistake in this evaluation, and it is easy to make when all three market themselves as AI reporting.

A deadline is not a decision

The August 31, 2026 PowerScribe 360 renewal date forces movement, and vendors know it. That pressure is a reason to start the evaluation early, not a reason to shorten it. Every one of these products deserves a shadow period against your real case mix before a signature.

Decision support, you always sign

Whichever way this goes, the report is a draft and every flag is a suggestion. The responsible radiologist reviews, edits and signs each study, which keeps clinical judgment exactly where it belongs.

Good questions

RADPAIR and PowerScribe vs Radiological.ai, answered

RADPAIR is a web-based radiology reporting platform built around generative AI, founded in 2023 and based in Knoxville, Tennessee. Radiologists dictate naturally and the platform handles punctuation, formatting and template population, then drafts findings and impressions for review. There is nothing to install, and the company also sells enterprise licensing to practices and health systems.

Yes, in the sense that it replaces the same layer. RADPAIR is where the report gets dictated and written, which is exactly the job PowerScribe does today, so running both would be redundant. The practical questions are whether it connects to your PACS and RIS the way your current setup does, and whether your existing templates and macros survive the move.

They occupy different layers. RADPAIR is a full reporting platform you dictate into, so it replaces your reporting workstation. Rad AI is not a reporting platform: Impressions generates the impression inside the system you already use, and Continuity tracks follow-up recommendations after the report is signed. You could run Rad AI alongside PowerScribe. You would not run RADPAIR alongside PowerScribe.

Yes. Intelerad announced a prime partnership with RADPAIR on May 20, 2025, combining Intelerad workflow orchestration with RADPAIR agentic AI to automate portions of the reporting workflow and pre-populate reports for review and approval. Intelerad is now a GE HealthCare company, which is worth knowing if you are already an Intelerad site.

RADPAIR is the only one of the three that publishes anything. The company offers a 7-day trial with 20 free reports and no credit card, then a pay-as-you-go credit model for individual radiologists, with enterprise licensing quoted for practices, teleradiology groups and health systems. Neither PowerScribe nor Rad AI publishes list pricing, so both require a scoping call.

That figure comes from the Intelerad partnership announcement, which describes it as early user feedback of a 30% to 40% gain compared with traditional smart reporting solutions. It is a vendor-reported number from early users, not a published study, and it is measured against structured reporting rather than against nothing. Treat it as a reason to run your own shadow period, not as a result you can budget against.

Neither is better in the abstract, and the honest split is by situation. PowerScribe wins when deep existing integration, template inventory and enterprise support relationships are the dominant cost of change, and PowerScribe One preserves 360 templates on the upgrade path. RADPAIR wins when you want out of an installed workstation, work across multiple systems, or want to trial a platform before a contract exists.

Not immediately, but the clock is explicit. Annual renewals and maintenance ended on August 31, 2026, and full support ends on August 31, 2027. Running unsupported reporting software is a risk decision your group has to make deliberately rather than by drift. Most groups use the renewal date as the trigger to evaluate rather than the date they must have migrated by.

No, and no serious vendor in this category claims otherwise. Every one of these products produces a draft. The responsible radiologist reads the study, reviews and edits the generated text, and signs the final report. The efficiency claims all describe time saved in producing that draft, not a report that goes out unread.

Four things, in the same email so the answers are comparable. What exactly connects to our PACS and RIS, and who builds that interface. What happens to our existing templates and macros in a migration. What the fully loaded first-year total is including integration and training. And what the renewal price looks like in year three, in writing, once the product is embedded in the workflow.

More comparisons

See how Radiological.ai compares

vs Aidoc

Aidoc alternative

One assistant across the whole read, not acute triage alone.

vs Rad AI

Rad AI alternative

Drafting plus flagging and triage, in one assistant.

vs DeepHealth

DeepHealth alternative

Reporting AI without buying it from a competitor.

vs Fluency for Imaging

PowerScribe vs Fluency for Imaging

The two reporting platforms most US groups actually shortlist.

vs Annalise.ai

Annalise.ai alternative

Finding flags plus triage and drafting, together.

vs Nuance PowerScribe

Nuance PowerScribe alternative

More than dictation: flagging, triage and drafting.

vs Qure.ai

Qure.ai alternative

Flags plus triage and drafting, in one assistant.

vs Viz.ai

Viz.ai alternative

Beyond acute stroke triage, across the whole read.

vs Nuance DAX

Nuance DAX alternative

Built for the read, not for the patient conversation.

vs Lunit

Lunit alternative

One assistant across the whole read, not detection on two modalities.

vs Gleamer

Gleamer alternative

One assistant across X-ray, CT and MRI, not a suite of per-exam detectors.

vs PowerScribe One

PowerScribe One vs 360

What actually changes in the cloud move, and the third option.

vs Sirona Medical

Sirona Medical alternative

Add the assistant to the PACS you already run, without replacing the stack.

vs New Lantern

New Lantern alternative

AI drafting and triage on the PACS you keep, not a new platform.

vs RapidAI

RapidAI alternative

Past the stroke pathway, across the whole reading list.

vs Dragon Medical One

Dragon Medical One pricing

Microsoft publishes no price. Here are 25 real federal contracts that do.

vs PowerScribe

PowerScribe pricing

No list price exists. Here are the only verifiable numbers that do.

vs PowerScribe

PowerScribe templates

What AutoText actually is, how to get yours out, and what survives a migration.

vs Aidoc and Viz.ai

Aidoc vs Viz.ai

Three acute triage platforms, compared on what they were each built to do.

vs vRad (Virtual Radiologic)

vRad alternative

vRad publishes no rate card. 357 federal contract awards do.

vs ONRAD

ONRAD alternative

ONRAD publishes no rate card. 80 federal contract awards do.

vs Real Radiology

Real Radiology alternative

Real Radiology publishes no rate card. 41 Army and VA contract awards do.

vs Experity Teleradiology

Experity Teleradiology alternative

The urgent care reading service that started as one Scottsdale radiologist and now sits inside an EMR company.

vs Sectra PACS

Sectra PACS alternative

The PACS that keeps winning satisfaction surveys, sold as a cloud subscription with no public price.

vs Visage PACS

Visage PACS alternative

The fastest-growing enterprise viewer in US radiology, priced per transaction and disclosed deal by deal.

vs Intelerad PACS

Intelerad PACS alternative

The teleradiology favorite, now a GE HealthCare business, with a renewal conversation that just changed.

vs Exa PACS

Exa PACS alternative

Often sold alongside a Konica X-ray room, with a thin public record you should fill in before you sign.

vs GE Centricity PACS

GE Centricity PACS alternative

An aging install base, three GE PACS lines under one owner, and a recall record you should read before the renewal.

vs Agfa PACS

Agfa PACS alternative

A Best in KLAS platform, a federal record over $300 million, and an IMPAX install base being moved to the cloud.

vs McKesson PACS

McKesson PACS alternative

A Horizon Medical Imaging install base now owned by Optum, a $98 million federal record and a cloud PACS sold per study.

vs Mach7

Mach7 alternative

A Vermont-run, ASX-listed enterprise imaging vendor with a new CEO, falling revenue and a seat on the VA teleradiology PACS.

vs iCAD

iCAD ProFound AI alternative

The first FDA-cleared AI for breast tomosynthesis, now owned by RadNet, the largest operator of US outpatient imaging centers.

vs ScreenPoint Transpara

Transpara alternative

Dutch mammography AI sold in the US through Siemens Healthineers and Fujifilm units, with the strongest trial record in the category.

vs Cortechs.ai NeuroQuant

NeuroQuant alternative

The longest-cleared brain volumetrics product in the US, bought by imaging centers, neurology groups, the VA and military hospitals.

vs Avicenna.AI CINA

Avicenna AI alternative

CT triage for stroke, pulmonary embolism and spine fractures, usually bought inside a scanner or platform vendor's bundle.

vs VIDIStar

VIDIStar alternative

A Greenville cardiology PACS bought by Hitachi in 2018, inherited by Fujifilm in 2021 and sold today as Synapse Select.

vs Subtle Medical

Subtle Medical alternative

Two vendor-neutral MRI acceleration products, four scanner makers with their own, and the FDA and federal purchase records behind each.

See every radiology use case

From the blog: what the PowerScribe 360 end of life means for radiology groups, how much radiology AI costs, and the full comparison of the best AI radiology software in 2026.

See how Radiological.ai reads alongside your group

One assistant that flags suspected findings, prioritizes the worklist, and drafts the structured report on X-ray, CT and MRI. You review and sign every study.

See pricing

Decision support for qualified clinicians. Radiological.ai does not provide a diagnosis and is not a substitute for professional medical judgment.